Baillie Gifford & CO Dexcom Inc Transaction History

Baillie Gifford & CO

  • $114 Billion
  • Q4 2025

A detailed history of Baillie Gifford & CO transactions in Dexcom Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 15,552,587 shares of DXCM stock, worth $903 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
15,552,587
Previous 15,882,168 2.08%
Holding current value
$903 Million
Previous $1.07 Billion 15.51%
% of portfolio
0.79%
Previous 0.84%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026
SELL
$54.84 - $71.06 $18.1 Million - $23.4 Million
-329,581 Reduced 2.08%
15,552,587 $903 Million
Q3 2025

Oct 31, 2025
SELL
$66.46 - $89.53 $54.7 Million - $73.7 Million
-823,027 Reduced 4.93%
15,882,168 $1.07 Billion
Q2 2025

Aug 06, 2025
BUY
$59.83 - $87.57 $151 Million - $221 Million
2,525,365 Added 17.81%
16,705,195 $1.46 Billion
Q1 2025

May 07, 2025
SELL
$67.74 - $90.75 $29.3 Million - $39.3 Million
-432,962 Reduced 2.96%
14,179,830 $968 Million
Q4 2024

Jan 31, 2025
SELL
$65.68 - $81.01 $26.6 Million - $32.8 Million
-404,874 Reduced 2.7%
14,612,792 $1.14 Billion
Q3 2024

Nov 05, 2024
SELL
$64.0 - $116.06 $19.7 Million - $35.8 Million
-308,265 Reduced 2.01%
15,017,666 $1.01 Billion
Q2 2024

Jul 25, 2024
SELL
$110.31 - $140.45 $40 Million - $50.9 Million
-362,465 Reduced 2.31%
15,325,931 $1.74 Billion
Q1 2024

May 01, 2024
SELL
$114.22 - $140.1 $95 Million - $117 Million
-831,917 Reduced 5.04%
15,688,396 $2.18 Billion
Q4 2023

Jan 26, 2024
SELL
$75.49 - $124.16 $12.2 Million - $20.1 Million
-162,191 Reduced 0.97%
16,520,313 $2.05 Billion
Q3 2023

Nov 13, 2023
SELL
$86.06 - $137.93 $3.51 Million - $5.63 Million
-40,794 Reduced 0.24%
16,682,504 $1.56 Billion
Q2 2023

Jul 28, 2023
SELL
$112.47 - $130.98 $48.8 Million - $56.9 Million
-434,201 Reduced 2.53%
16,723,298 $2.15 Billion
Q1 2023

May 03, 2023
SELL
$104.0 - $122.92 $15.1 Million - $17.9 Million
-145,386 Reduced 0.84%
17,157,499 $1.99 Billion
Q4 2022

Jan 24, 2023
SELL
$84.98 - $122.67 $68.2 Million - $98.4 Million
-802,293 Reduced 4.43%
17,302,885 $1.96 Billion
Q3 2022

Oct 27, 2022
BUY
$76.35 - $94.18 $441,226 - $544,266
5,779 Added 0.03%
18,105,178 $1.46 Billion
Q2 2022

Aug 08, 2022
BUY
$67.99 - $132.89 $921 Million - $1.8 Billion
13,545,106 Added 297.41%
18,099,399 $1.35 Billion
Q1 2022

May 05, 2022
BUY
$94.08 - $130.2 $4.24 Million - $5.87 Million
45,107 Added 1.0%
4,554,293 $2.33 Billion
Q4 2021

Jan 20, 2022
SELL
$129.87 - $162.82 $109 Million - $137 Million
-840,632 Reduced 15.71%
4,509,186 $2.42 Billion
Q3 2021

Oct 19, 2021
BUY
$106.71 - $143.18 $14.2 Million - $19.1 Million
133,197 Added 2.55%
5,349,818 $2.93 Billion
Q2 2021

Aug 02, 2021
SELL
$80.99 - $107.93 $9.2 Million - $12.3 Million
-113,617 Reduced 2.13%
5,216,621 $2.23 Billion
Q1 2021

May 06, 2021
SELL
$84.79 - $104.74 $10.5 Million - $12.9 Million
-123,606 Reduced 2.27%
5,330,238 $1.92 Billion
Q4 2020

Feb 10, 2021
BUY
$78.0 - $104.5 $95.6 Million - $128 Million
1,225,388 Added 28.98%
5,453,844 $2.02 Billion
Q3 2020

Nov 12, 2020
SELL
$95.51 - $112.95 $29.9 Million - $35.4 Million
-313,528 Reduced 6.9%
4,228,456 $1.74 Billion
Q2 2020

Aug 12, 2020
SELL
$62.68 - $105.34 $18.1 Million - $30.4 Million
-288,568 Reduced 5.97%
4,541,984 $1.84 Billion
Q1 2020

May 08, 2020
BUY
$47.79 - $75.63 $728,940 - $1.15 Million
15,253 Added 0.32%
4,830,552 $1.3 Billion
Q4 2019

Feb 10, 2020
SELL
$36.62 - $57.29 $367,005 - $574,160
-10,022 Reduced 0.21%
4,815,299 $1.05 Billion
Q3 2019

Nov 07, 2019
SELL
$35.53 - $43.8 $354,163 - $436,598
-9,968 Reduced 0.21%
4,825,321 $720 Million
Q2 2019

Aug 08, 2019
SELL
$27.84 - $38.92 $2.35 Million - $3.29 Million
-84,435 Reduced 1.72%
4,835,289 $725 Million
Q1 2019

May 01, 2019
SELL
$28.07 - $38.18 $271,745 - $369,620
-9,681 Reduced 0.2%
4,919,724 $0
Q4 2018

Feb 14, 2019
SELL
$26.99 - $37.37 $4.45 Million - $6.16 Million
-164,792 Reduced 3.23%
4,929,405 $591 Million
Q3 2018

Nov 13, 2018
SELL
$23.35 - $36.72 $2.43 Million - $3.81 Million
-103,870 Reduced 2.0%
5,094,197 $729 Million
Q2 2018

Jul 17, 2018
SELL
$17.54 - $25.22 $3.85 Million - $5.54 Million
-219,757 Reduced 4.06%
5,198,067 $494 Million
Q1 2018

May 10, 2018
SELL
$13.06 - $18.54 $1.73 Million - $2.46 Million
-132,760 Reduced 2.39%
5,417,824 $402 Million
Q4 2017

Feb 13, 2018
SELL
$11.12 - $15.38 $2.52 Million - $3.49 Million
-227,050 Reduced 3.93%
5,550,584 $319 Million
Q3 2017

Oct 20, 2017
SELL
$11.36 - $18.98 $3.6 Million - $6.01 Million
-316,837 Reduced 5.2%
5,777,634 $283 Million
Q2 2017

Aug 10, 2017
BUY
N/A
6,094,471
6,094,471 $446 Million

Others Institutions Holding DXCM

# of Institutions
1,080
Shares Held
375M
Call Options Held
6.76M
Put Options Held
7.24M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email